BREAKING NEWS: Moderna asks FDA to expand emergency use of COVID-19 vaccine to children ages 12-17 – making it second injection approved for children
- Moderna Inc has asked FDA to expand emergency use of COVID-19 vaccine to Americans ages 12 to 17
- Recent clinical trial data showed the vaccine was 100 percent safe and effective in younger teens
- If approved, it would provide parents with a second option to vaccinate children before the start of the 2021 school year
Moderna Inc has asked the U.S. Food and Drug Administration (FDA) to expand emergency use of the COVID-19 vaccine to Americans between the ages of 12 and 17.
When the vaccine was originally approved for use by the FDA in December 2020, it was only for those ages 18 and older.
However, recent data from phase III clinical trials showed that no children who received the immunization became sick with the virus within 14 days of their second dose, while four children who received the placebo later tested positive.
According to Moderna, this is “consistent with a vaccine effectiveness of 100 percent.”
It comes just four weeks after Pfizer-BioNTech received FDA approval to administer the vaccine to children between the ages of 12 and 15.
Moderna Inc has asked the FDA to expand emergency use of the COVID-19 vaccine to Americans between the ages of 12 and 17. Pictured: A health worker holds a vial of Moderna COVID-19 vaccine at a pop-up vaccination site in New York City, Jan. 29
This is a latest news item and will be updated.